| Dr Anita Lynn Weisberger, MD | |
|
1955 Dixie Hwy, Ste C, Ft Wright, KY 41011-2792 | |
| (859) 341-5550 | |
| (859) 344-3782 |
| Full Name | Dr Anita Lynn Weisberger |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 1955 Dixie Hwy, Ft Wright, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922077593 | NPI | - | NPPES |
| 64068141 | Medicaid | KY | |
| 2417852 | Medicaid | OH | |
| P01933970 | Other | OH | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35-082722 (Ohio) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 38229 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christ Hospital | Cincinnati, OH | Hospital |
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christ Hospital Medical Specialists Llc | 6507998432 | 98 |
| Christ Hospital Medical Specialists Llc | 6507998432 | 98 |
News Archive
During the past two decades there has been a significant increase in the percentage of patients who have a high number of lymph nodes evaluated during colon cancer operations, but this improvement is not associated with an increase in the overall proportion of colon cancers that are node positive, according to a study in the September 14 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced receipt of the final $2.0 million payment from Kaketsuken under the $8.0 million collaboration announced in November 2009. The agreement involves multiple proprietary XOMA antibody research and development technologies, including a new XOMA phage display library, and a suite of integrated information and data management systems.
In an opinion piece in Population Service International's "Impact" magazine, Rep. Nita Lowey (D-N.Y.) writes, "Unfortunately, the Republican majority in the House of Representatives has empowered extremists with zeal for both broad, haphazard budget cuts and a commitment to rolling back women's health rights,"
New research published by University of Utah S.J. Quinney College of Law Professor Jorge Contreras in Science this week explores the current state of sharing resources in the biomedical research field and whether the fragmentation of property ownership can stifle research progress, instead of advancing it.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
› Verified 7 days ago
| Entity Name | Christ Hospital Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124341649 PECOS PAC ID: 6507998432 Enrollment ID: O20101112000568 |
News Archive
During the past two decades there has been a significant increase in the percentage of patients who have a high number of lymph nodes evaluated during colon cancer operations, but this improvement is not associated with an increase in the overall proportion of colon cancers that are node positive, according to a study in the September 14 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced receipt of the final $2.0 million payment from Kaketsuken under the $8.0 million collaboration announced in November 2009. The agreement involves multiple proprietary XOMA antibody research and development technologies, including a new XOMA phage display library, and a suite of integrated information and data management systems.
In an opinion piece in Population Service International's "Impact" magazine, Rep. Nita Lowey (D-N.Y.) writes, "Unfortunately, the Republican majority in the House of Representatives has empowered extremists with zeal for both broad, haphazard budget cuts and a commitment to rolling back women's health rights,"
New research published by University of Utah S.J. Quinney College of Law Professor Jorge Contreras in Science this week explores the current state of sharing resources in the biomedical research field and whether the fragmentation of property ownership can stifle research progress, instead of advancing it.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anita Lynn Weisberger, MD 1955 Dixie Hwy Ste C, Ft Wright, KY 41011-2882 Ph: (859) 292-9215 | Dr Anita Lynn Weisberger, MD 1955 Dixie Hwy, Ste C, Ft Wright, KY 41011-2792 Ph: (859) 341-5550 |
News Archive
During the past two decades there has been a significant increase in the percentage of patients who have a high number of lymph nodes evaluated during colon cancer operations, but this improvement is not associated with an increase in the overall proportion of colon cancers that are node positive, according to a study in the September 14 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced receipt of the final $2.0 million payment from Kaketsuken under the $8.0 million collaboration announced in November 2009. The agreement involves multiple proprietary XOMA antibody research and development technologies, including a new XOMA phage display library, and a suite of integrated information and data management systems.
In an opinion piece in Population Service International's "Impact" magazine, Rep. Nita Lowey (D-N.Y.) writes, "Unfortunately, the Republican majority in the House of Representatives has empowered extremists with zeal for both broad, haphazard budget cuts and a commitment to rolling back women's health rights,"
New research published by University of Utah S.J. Quinney College of Law Professor Jorge Contreras in Science this week explores the current state of sharing resources in the biomedical research field and whether the fragmentation of property ownership can stifle research progress, instead of advancing it.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
› Verified 7 days ago